-
1
-
-
33845903306
-
Are laboratory-based antibiograms reliable to guide the selection of empirical antimicrobial treatment in patients with hospital-acquired infections?
-
DOI 10.1093/jac/dkl434
-
Bantar, C., G. Alcazar, D. Franco, F. Salamone, and M. E. Oliva. 2007. Are laboratory-based antibiograms reliable to guide the selection of empirical antimicrobial treatment in patients with hospital-acquired infections? J. Antimicrob. Chemother. 59:140-143. (Pubitemid 46017917)
-
(2007)
Journal of Antimicrobial Chemotherapy
, vol.59
, Issue.1
, pp. 140-143
-
-
Bantar, C.1
Alcazar, G.2
Franco, D.3
Salamone, F.4
Vesco, E.5
Stieben, T.6
Obaid, F.7
Fiorillo, A.8
Izaguirre, M.9
Oliva, M.E.10
-
2
-
-
33747692208
-
Comparison of unit-specific and hospital-wide antibiograms: Potential implications for selection of empirical antimicrobial therapy
-
DOI 10.1086/505921
-
Binkley, S., et al. 2006. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect. Control Hosp. Epidemiol. 27:682-687. (Pubitemid 44271948)
-
(2006)
Infection Control and Hospital Epidemiology
, vol.27
, Issue.7
, pp. 682-687
-
-
Binkley, S.1
Fishman, N.O.2
LaRosa, L.A.3
Marr, A.M.4
Nachamkin, I.5
Wordell, D.6
Bilker, W.B.7
Lautenbach, E.8
-
3
-
-
0025981930
-
Correlations between therapeutic response of leukemias and in vitro drug sensitivity assay
-
Bosanquet, E. G. 1991. Correlations between therapeutic response of leukemias and in vitro drug sensitivity assay. Lancet 337:711-714.
-
(1991)
Lancet
, vol.337
, pp. 711-714
-
-
Bosanquet, E.G.1
-
5
-
-
0037235347
-
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis
-
DOI 10.1086/345476
-
Cosgrove, S., et al. 2003. Mortality related to methicillin-resistant Staphylococcus aureus compared to methicillin-susceptibile S. aureus: a meta-analysis. Clin. Infect. Dis. 36:53-59. (Pubitemid 36099097)
-
(2003)
Clinical Infectious Diseases
, vol.36
, Issue.1
, pp. 53-59
-
-
Cosgrove, S.E.1
Sakoulas, G.2
Perencevich, E.N.3
Schwaber, M.J.4
Karchmer, A.W.5
Carmeli, Y.6
-
6
-
-
62949178700
-
Effect of differences in MIC values on clinical outcomes in patients with blood stream infection caused by Gram-negative organisms treated with levofloxacin
-
Defife, R., M. H. Scheetz, J. M. Feinglass, M. J. Psotelnick, and K. Scarsi. 2009. Effect of differences in MIC values on clinical outcomes in patients with blood stream infection caused by Gram-negative organisms treated with levofloxacin. Antimicrob. Agents Chemother. 53:1074-1079.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 1074-1079
-
-
Defife, R.1
Scheetz, M.H.2
Feinglass, J.M.3
Psotelnick, M.J.4
Scarsi, K.5
-
7
-
-
0026704883
-
In vitro activity of loracarbef and effects of susceptibility test methods
-
Doern, G. V. 1992. In vitro activity of loracarbef and effects of susceptibility test methods. Am. J. Med. 92:7S-15S.
-
(1992)
Am. J. Med.
, vol.92
-
-
Doern, G.V.1
-
8
-
-
0029085669
-
Interpretive criteria for in vitro antimicrobial susceptibility tests
-
Doern, G. V. 1995. Interpretive criteria for in vitro antimicrobial susceptibility tests. Rev. Med. Microbiol. 6:126-136.
-
(1995)
Rev. Med. Microbiol.
, vol.6
, pp. 126-136
-
-
Doern, G.V.1
-
9
-
-
66949131416
-
Short-term and medium-term outcomes of quinolone- resistant Campylobacter infection
-
Evans, M. R., et al. 2009. Short-term and medium-term outcomes of quinolone- resistant Campylobacter infection. Clin. Infect. Dis. 48:1500-1506.
-
(2009)
Clin. Infect. Dis.
, vol.48
, pp. 1500-1506
-
-
Evans, M.R.1
-
10
-
-
0027161344
-
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
-
Forrest, A., et al. 1993. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob. Agents Chemother. 37:1073-1081. (Pubitemid 23141323)
-
(1993)
Antimicrobial Agents and Chemotherapy
, vol.37
, Issue.5
, pp. 1073-1081
-
-
Forrest, A.1
Nix, D.E.2
Ballow, C.H.3
Goss, T.F.4
Birmingham, M.C.5
Schentag, J.J.6
-
11
-
-
0019342866
-
Worldwide clinical experience with cefoperazone
-
Gerber, A. U., and W. A. Craig. 1981. Worldwide clinical experience with cefoperazone. Drugs 22:108-118.
-
(1981)
Drugs
, vol.22
, pp. 108-118
-
-
Gerber, A.U.1
Craig, W.A.2
-
12
-
-
0024387119
-
Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients
-
Hilf, M., et al. 1989. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am. J. Med. 87:541-546.
-
(1989)
Am. J. Med.
, vol.87
, pp. 541-546
-
-
Hilf, M.1
-
13
-
-
0030797608
-
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: Analysis of the correlations between in vitro test results and clinical response
-
DOI 10.1016/S0732-8893(97)00013-8, PII S0732889397000138
-
Jones, R. N., and M. N. Dudley. 1997. Microbiological and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/ sulbactam: analysis of the correlations between in vitro test results and clinical response. Diagn. Microbiol. Infect. Dis. 28:5-18. (Pubitemid 27314865)
-
(1997)
Diagnostic Microbiology and Infectious Disease
, vol.28
, Issue.1
, pp. 5-18
-
-
Jones, R.N.1
Dudley, M.N.2
-
14
-
-
80053217117
-
Molecular detection of resistance determinants
-
Ledeboer, N. A., and R. L. Hodinka. 2011. Molecular detection of resistance determinants. J. Clin. Microbiol. 49(Suppl.):S20-S24.
-
(2011)
J. Clin. Microbiol.
, vol.49
, Issue.SUPPL.
-
-
Ledeboer, N.A.1
Hodinka, R.L.2
-
16
-
-
0037232281
-
Detection and treatment of bloodstream infection: Laboratory reporting and antimicrobial management
-
DOI 10.1128/JCM.41.1.495-497.2003
-
Munson, E. L., D. J. Diekema, S. E. Beekmann, K. C. Chapin, and G. V. Doern. 2003. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J. Clin. Microbiol. 41:495-497. (Pubitemid 36098632)
-
(2003)
Journal of Clinical Microbiology
, vol.41
, Issue.1
, pp. 495-497
-
-
Munson, E.L.1
Diekema, D.J.2
Beekmann, S.E.3
Chapin, K.C.4
Doern, G.V.5
-
17
-
-
80053198237
-
Analysis of the clinical predictive value of quantitative and qualitative susceptibility tests with cefotaxime
-
abstr. 545
-
Murray, P. R., R. Jones, and W. Novick. 1983. Analysis of the clinical predictive value of quantitative and qualitative susceptibility tests with cefotaxime. Abstr. 23rd Intersci. Conf. Antimicrob. Agents Chemother. abstr. 545, p. 182.
-
(1983)
Abstr. 23rd Intersci. Conf. Antimicrob. Agents Chemother.
, pp. 182
-
-
Murray, P.R.1
Jones, R.2
Novick, W.3
-
18
-
-
0034465384
-
Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: Findings of a multicenter prospective observational trial
-
Nguyen, M. H., V. L. Yu, and A. J. Morris. 2000. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin. Infect. Dis. 30:870-876.
-
(2000)
Clin. Infect. Dis.
, vol.30
, pp. 870-876
-
-
Nguyen, M.H.1
Yu, V.L.2
Morris, A.J.3
-
19
-
-
0037108380
-
Has antifungal susceptibility testing come of age?
-
DOI 10.1086/342384
-
Rex, J. H., and M. A. Pfaller. 2002. Has antifungal susceptibility testing come of age? Clin. Infect. Dis. 35:982-989. (Pubitemid 35178316)
-
(2002)
Clinical Infectious Diseases
, vol.35
, Issue.8
, pp. 982-989
-
-
Rex, J.H.1
Pfaller, M.A.2
-
20
-
-
0021191660
-
Acute cystitis: A prospective study of laboratory tests and duration of therapy
-
Schultz, H. J., L. A. McCaffrey, T. F. Keys, and F. T. Nobrega. 1984. Acute cystitis: a prospective study of laboratory tests and duration of therapy. Mayo Clin. Proc. 59:391-397. (Pubitemid 14117996)
-
(1984)
Mayo Clinic Proceedings
, vol.59
, Issue.6
, pp. 391-397
-
-
Schultz, H.J.1
McCaffrey, L.A.2
Keys, T.F.3
Nobrega, F.T.4
-
21
-
-
0026511688
-
Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: A retrospective analysis
-
Snydman, D. R., G. J. Cuchural, L. McDermott, and M. Gill. 1992. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis. Antimicrob. Agents Chemother. 36:540-544.
-
(1992)
Antimicrob. Agents Chemother.
, vol.36
, pp. 540-544
-
-
Snydman, D.R.1
Cuchural, G.J.2
McDermott, L.3
Gill, M.4
-
22
-
-
0020595174
-
Discrepancies between in vitro activity and in vivo response to antimicrobial agents
-
Washington, J. A. 1983. Discrepancies between in vitro activity and in vivo response to antimicrobial agents. Diagn. Microbiol. Infect. Dis. 1:25-31.
-
(1983)
Diagn. Microbiol. Infect. Dis.
, vol.1
, pp. 25-31
-
-
Washington, J.A.1
-
23
-
-
0020667691
-
The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults
-
Weinstein, M. P., J. R. Murray, L. B. Reller, and K. A. Lichtenstein. 1983. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. Rev. Infect. Dis. 5:54-70.
-
(1983)
Rev. Infect. Dis.
, vol.5
, pp. 54-70
-
-
Weinstein, M.P.1
Murray, J.R.2
Reller, L.B.3
Lichtenstein, K.A.4
-
24
-
-
77953097553
-
Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of communityonset bacteremic urinary tract infections
-
Yang, Y. S., et al. 2010. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of communityonset bacteremic urinary tract infections. J. Microbiol. Immunol. Infect. 43:194-199.
-
(2010)
J. Microbiol. Immunol. Infect.
, vol.43
, pp. 194-199
-
-
Yang, Y.S.1
|